BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee JK, Paine MF, Brouwer KL. Sulindac and its metabolites inhibit multiple transport proteins in rat and human hepatocytes. J Pharmacol Exp Ther 2010;334:410-8. [PMID: 20430841 DOI: 10.1124/jpet.110.165852] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Równicka-zubik J, Sułkowska A, Maciążek-jurczyk M, Sułkowski L, Sułkowski WW. Effect of Denaturating Agents on the Structural Alterations and Drug-Binding Capacity of Human and Bovine Serum Albumin. Spectroscopy Letters 2012;45:520-9. [DOI: 10.1080/00387010.2011.650342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Chitturi S, Farrell GC. Drug-Induced Liver Disease. In: Schiff ER, Maddrey WC, Sorrell MF, editors. Schiff's Diseases of the Liver. Oxford: Wiley-Blackwell; 2011. pp. 703-83. [DOI: 10.1002/9781119950509.ch27] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Cha HJ, Ahn J, Jeong J, Park M, Kim EJ, Kang H, Kim HS, Seong W, Jeong H. Identification of modulated mRNAs and proteins in human primary hepatocytes treated with non-steroidal anti-inflammatory drugs. Mol Cell Toxicol 2015;11:335-42. [DOI: 10.1007/s13273-015-0033-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
4 Minagawa K, Berber MR, Hafez IH, Mori T, Tanaka M. Target delivery and controlled release of the chemopreventive drug sulindac by using an advanced layered double hydroxide nanomatrix formulation system. J Mater Sci Mater Med 2012;23:973-81. [PMID: 22350776 DOI: 10.1007/s10856-012-4566-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
5 Yang K, Brouwer KL. Hepatocellular exposure of troglitazone metabolites in rat sandwich-cultured hepatocytes lacking Bcrp and Mrp2: interplay between formation and excretion. Drug Metab Dispos 2014;42:1219-26. [PMID: 24799397 DOI: 10.1124/dmd.114.057190] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
6 Ishida K, Ullah M, Tóth B, Juhasz V, Unadkat JD. Successful Prediction of In Vivo Hepatobiliary Clearances and Hepatic Concentrations of Rosuvastatin Using Sandwich-Cultured Rat Hepatocytes, Transporter-Expressing Cell Lines, and Quantitative Proteomics. Drug Metab Dispos 2018;46:66-74. [PMID: 29084782 DOI: 10.1124/dmd.117.076539] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 6.4] [Reference Citation Analysis]
7 Ito K, Sjöstedt N, Brouwer KLR. Mechanistic Modeling of the Hepatic Disposition of Estradiol-17β-Glucuronide in Sandwich-Cultured Human Hepatocytes. Drug Metab Dispos 2020;48:116-22. [PMID: 31744810 DOI: 10.1124/dmd.119.088898] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Kindla J, Müller F, Mieth M, Fromm MF, König J. Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport. Drug Metab Dispos. 2011;39:1047-1053. [PMID: 21389119 DOI: 10.1124/dmd.110.037622] [Cited by in Crossref: 81] [Cited by in F6Publishing: 75] [Article Influence: 7.4] [Reference Citation Analysis]
9 Ramboer E, Vanhaecke T, Rogiers V, Vinken M. Primary hepatocyte cultures as prominent in vitro tools to study hepatic drug transporters. Drug Metab Rev 2013;45:196-217. [PMID: 23368091 DOI: 10.3109/03602532.2012.756010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
10 Fardel O, Moreau A, Le Vée M, Denizot C, Parmentier Y. Evaluation of Drug Biliary Excretion Using Sandwich-Cultured Human Hepatocytes. Eur J Drug Metab Pharmacokinet 2019;44:13-30. [PMID: 30167999 DOI: 10.1007/s13318-018-0502-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
11 Boelsterli UA. Mechanisms Underlying the Hepatotoxicity of Nonsteroidal Antiinflammatory Drugs. Drug-Induced Liver Disease. Elsevier; 2013. pp. 343-67. [DOI: 10.1016/b978-0-12-387817-5.00021-2] [Cited by in Crossref: 8] [Article Influence: 0.9] [Reference Citation Analysis]
12 Zamek-gliszczynski MJ, Chu X, Polli JW, Paine MF, Galetin A. Understanding the Transport Properties of Metabolites: Case Studies and Considerations for Drug Development. Drug Metab Dispos 2014;42:650-64. [DOI: 10.1124/dmd.113.055558] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
13 Yang K, Köck K, Sedykh A, Tropsha A, Brouwer KL. An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters. J Pharm Sci 2013;102:3037-57. [PMID: 23653385 DOI: 10.1002/jps.23584] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 7.9] [Reference Citation Analysis]
14 Marion TL, Perry CH, St Claire RL 3rd, Yue W, Brouwer KL. Differential disposition of chenodeoxycholic acid versus taurocholic acid in response to acute troglitazone exposure in rat hepatocytes. Toxicol Sci 2011;120:371-80. [PMID: 21262925 DOI: 10.1093/toxsci/kfr014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
15 De Bruyn T, Chatterjee S, Fattah S, Keemink J, Nicolaï J, Augustijns P, Annaert P. Sandwich-cultured hepatocytes: utility for in vitro exploration of hepatobiliary drug disposition and drug-induced hepatotoxicity. Expert Opin Drug Metab Toxicol. 2013;9:589-616. [PMID: 23452081 DOI: 10.1517/17425255.2013.773973] [Cited by in Crossref: 86] [Cited by in F6Publishing: 75] [Article Influence: 9.6] [Reference Citation Analysis]
16 Parilti R, Riva R, Howdle SM, Dupont-Gillain C, Jerome C. Sulindac encapsulation and release from functional poly(HEMA) microparticles prepared in supercritical carbon dioxide. Int J Pharm 2018;549:161-8. [PMID: 30056217 DOI: 10.1016/j.ijpharm.2018.07.060] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
17 Kolarić TO, Ninčević V, Smolić R, Smolić M, Wu GY. Mechanisms of Hepatic Cholestatic Drug Injury. J Clin Transl Hepatol 2019;7:86-92. [PMID: 30944824 DOI: 10.14218/JCTH.2018.00042] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
18 Yuan Z, Li Y, Liu Z, Feng S, Zhou H, Liu C, Liu L, Xie Y. Role of tangeretin as a potential bioavailability enhancer for silybin: Pharmacokinetic and pharmacological studies. Pharmacological Research 2018;128:153-66. [DOI: 10.1016/j.phrs.2017.09.019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]